| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |